Recent News

November 7, 2012 at 5:03 PM EST

Summary Toggle Proteostasis Therapeutics to Present at Lazard Capital Markets 9th Annual Healthcare Conference

Cambridge, Mass., November 7, 2012 — Proteostasis Therapeutics, Inc., a company developing novel therapeutics that regulate protein homeostasis to improve outcomes for patients with neurodegenerative and orphan diseases, announced today that Mark J.

Releasee5033e9e-944b-4bb6-aba1-cc4abbe62672_2061996.pdf 6.2 KB
November 7, 2012 at 4:58 PM EST

Summary Toggle Proteostasis Therapeutics to Present at Lazard Capital Markets 9th Annual Healthcare Conference

Cambridge, Mass., November 7, 2012 — Proteostasis Therapeutics, Inc., a company developing novel therapeutics that regulate protein homeostasis to improve outcomes for patients with neurodegenerative and orphan diseases, announced today that Mark J.

Release0fbb11a9-d895-457f-b5ec-0900f5d8c25d_2061995.pdf 6.2 KB
November 2, 2012 at 5:12 PM EDT

Summary Toggle Proteostasis Therapeutics Expands Management Team with Two Strategic Positions

Company adds CMO and Senior Vice President of Chemistry leading into two anticipated IND filings in 2014 and 2015 Cambridge, Mass., November 2, 2012 — Proteostasis Therapeutics, Inc., a company developing novel therapeutics that regulate protein homeostasis to improve outcomes for patients with

Release8196ac3f-1017-42dd-a434-16029ba022b6_2061998.pdf 11.9 KB
November 2, 2012 at 5:11 PM EDT

Summary Toggle Proteostasis Therapeutics Expands Management Team with Two Strategic Positions

Company adds CMO and Senior Vice President of Chemistry leading into two anticipated IND filings in 2014 and 2015 Cambridge, Mass., November 2, 2012 — Proteostasis Therapeutics, Inc., a company developing novel therapeutics that regulate protein homeostasis to improve outcomes for patients with

Releaseed92afef-7ab4-4557-801e-6c2f6ef0db99_2061997.pdf 11.9 KB
October 18, 2012 at 5:15 PM EDT

Summary Toggle Proteostasis Therapeutics Presents Data at Two Scientific Conferences for Lead Programs in Cystic Fibrosis and Parkinson’s Disease

Cambridge, Mass., October 18, 2012 — Proteostasis Therapeutics, Inc., a company developing novel therapeutics that regulate protein homeostasis to improve outcomes for patients with neurodegenerative and orphan diseases, announced today that company scientists made presentations at two premier

Releasef419e942-a38d-4e32-a530-14ae5f68d5cf_2062002.pdf 119.9 KB
October 18, 2012 at 5:14 PM EDT

Summary Toggle Proteostasis Therapeutics Presents Data at Two Scientific Conferences for Lead Programs in Cystic Fibrosis and Parkinson’s Disease

Cambridge, Mass., October 18, 2012 — Proteostasis Therapeutics, Inc., a company developing novel therapeutics that regulate protein homeostasis to improve outcomes for patients with neurodegenerative and orphan diseases, announced today that company scientists made presentations at two premier

Release11953cf3-151c-43e8-ac79-784e58f2d905_2062000.pdf 119.9 KB
October 18, 2012 at 5:13 PM EDT

Summary Toggle Proteostasis Therapeutics Presents Data at Two Scientific Conferences for Lead Programs in Cystic Fibrosis and Parkinson’s Disease

Cambridge, Mass., October 18, 2012 — Proteostasis Therapeutics, Inc., a company developing novel therapeutics that regulate protein homeostasis to improve outcomes for patients with neurodegenerative and orphan diseases, announced today that company scientists made presentations at two premier

Release23a1837a-d31e-4ea7-96d9-1df248c1d7b7_2061999.pdf 119.9 KB
October 10, 2012 at 5:16 PM EDT

Summary Toggle Proteostasis Therapeutics to Present Data at Two Upcoming Scientific Meetings

Cambridge, Mass., October 10, 2012 — Proteostasis Therapeutics, Inc., a company developing novel therapeutics that regulate protein homeostasis to improve outcomes for patients with neurodegenerative and orphan diseases, announced today that the Company will present data on its two lead programs at

Release2db6f40d-8d76-46ac-97ff-7803e5ac899d_2062004.pdf 7.4 KB
October 8, 2012 at 5:17 PM EDT

Summary Toggle Proteostasis Therapeutics to Present at 11th Annual BIO Investor Forum

Cambridge, Mass., October 8, 2012 — Proteostasis Therapeutics, Inc., a company developing novel therapeutics that regulate protein homeostasis to improve outcomes for patients with neurodegenerative and orphan diseases, announced today that Mark J. Enyedy, Chief Executive Officer, will present at

Release10aec564-bf1c-49b0-89b0-c934ccaaa328_2062007.pdf 6.1 KB
September 10, 2012 at 5:18 PM EDT

Summary Toggle Proteostasis Therapeutics to Present at Rodman & Renshaw 14th Annual Healthcare Conference

Cambridge, Mass., September 10, 2012 — Proteostasis Therapeutics, Inc., a company developing novel therapeutics that regulate protein homeostasis to improve outcomes for patients with neurodegenerative and orphan diseases, announced today that it will present at the Rodman & Renshaw 14th Annual

Releasee3a6d13b-170d-483c-a8ae-b00294c0ef36_2062008.pdf 5.9 KB